Emtricitabin-Tenofovir-Mepha

Emtricitabin-Tenofovir-Mepha is a medicine authorised by Swissmedic under authorisation number 66181. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 31 March 2017 and the authorisation is valid without a time limit. ATC code J05AR03 places the medicine in the group Antivirals for systemic use.

  • Dispensing category A
  • Authorisation number 66181
  • ATC J05AR03
  • Synthetic medicines
Authorisation data
Authorisation number66181
NameEmtricitabin-Tenofovir-Mepha
Full nameEmtricitabin-Tenofovir-Mepha, Filmtabletten
Authorisation holderMepha Pharma AG
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeJ05AR03
First authorisation31 March 2017
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Emtricitabin-Tenofovir-Mepha, FilmtablettenA31 March 2017

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
130Tablette(n)J05AR0308.03.0.A
230Tablette(n)J05AR0308.03.0.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Emtricitabin-Tenofovir-Mepha authorised in Switzerland?

Yes. Emtricitabin-Tenofovir-Mepha is authorised by Swissmedic under authorisation number 66181, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Emtricitabin-Tenofovir-Mepha have?

Emtricitabin-Tenofovir-Mepha is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Emtricitabin-Tenofovir-Mepha?

The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com